570 related articles for article (PubMed ID: 22056545)
1. Discriminative value of inflammatory biomarkers for suspected sepsis.
Tsalik EL; Jaggers LB; Glickman SW; Langley RJ; van Velkinburgh JC; Park LP; Fowler VG; Cairns CB; Kingsmore SF; Woods CW
J Emerg Med; 2012 Jul; 43(1):97-106. PubMed ID: 22056545
[TBL] [Abstract][Full Text] [Related]
2. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
[TBL] [Abstract][Full Text] [Related]
3. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
[TBL] [Abstract][Full Text] [Related]
4. [Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome].
Liu XL; Du B; Pan JQ; Xu Y; Hua BL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):48-52. PubMed ID: 15782493
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic values of procalcitonin, interleukin-6, C reactive protein and serum amyloid A in sepsis].
Fu Y; Chen J; Cai B; Zhang JL; Li LX; Wang LL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):702-5. PubMed ID: 23230743
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
Rey C; Los Arcos M; Concha A; Medina A; Prieto S; Martinez P; Prieto B
Intensive Care Med; 2007 Mar; 33(3):477-84. PubMed ID: 17260130
[TBL] [Abstract][Full Text] [Related]
10. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.
Oberhoffer M; Russwurm S; Bredle D; Chatzinicolaou K; Reinhart K
Intensive Care Med; 2000 Mar; 26 Suppl 2():S170-4. PubMed ID: 18470714
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.
Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S
J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339
[TBL] [Abstract][Full Text] [Related]
13. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
[TBL] [Abstract][Full Text] [Related]
15. [Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].
Dong Z; Jianxin Z; Haraguchi G; Arai H; Mitaka C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):478-9. PubMed ID: 25163104
[TBL] [Abstract][Full Text] [Related]
16. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.
Magrini L; Gagliano G; Travaglino F; Vetrone F; Marino R; Cardelli P; Salerno G; Di Somma S
Clin Chem Lab Med; 2014 Oct; 52(10):1465-72. PubMed ID: 24803611
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.
Pavcnik-Arnol M; Hojker S; Derganc M
Intensive Care Med; 2004 Jul; 30(7):1454-60. PubMed ID: 15127192
[TBL] [Abstract][Full Text] [Related]
19. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy.
Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J
Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin: a valuable indicator of infection in a medical ICU?
Suprin E; Camus C; Gacouin A; Le Tulzo Y; Lavoue S; Feuillu A; Thomas R
Intensive Care Med; 2000 Sep; 26(9):1232-8. PubMed ID: 11089747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
